Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
-
Athersys Announces Pricing of Public Offering of Common Stock
-
Pre-Open Stock Movers 03/11 (SSKN) (FNSR) (ULTA) Higher; (FXCM) (SGY) (RUN) Lower (more...)
-
Athersys (ATHX) PT Doubled to $10 at Maxim Group
-
Athersys (ATHX) PT Cut to $5 at Maxim Group; 'Buy' Maintained
-
Maxim Group's Jason Kolbert and Jason McCarthy Interviewed by The Life Sciences Report
-
Athersys (ATHX) PT Lifted to $9 at Maxim Group
-
Athersys (ATHX) Closes in on Major Milestone - Maxim
-
Maxim Group Maintains Bullish Outlook in Athersys (ATHX) Despite Trial Failure and Massive Sell-Off
-
Pre-Open Stock Movers 3/14: (HART) (MEET) (LMCA) Higher; (ARO) (ZBB) (PLUG) Lower (more...)
-
Athersys to Present at Regen Med Investor Day March 26th in New York
-
Athersys (ATHX) Prices 5M Common, 1.5M Warrants Direct Offering
-
Athersys Prices Registered Direct Offering of Common Stock and Warrants
-
Athersys (ATHX) Has Nearly 400% Upside, Maxim Group Says; PT Lifted to $10
-
Maxim Doubles Price Target on Athersys (ATHX)
-
Morning Movers 12/21: ATHX, CHTT, NTWK, QELP, BKRS, RFMI Higher; OGXI, GIGM, QTWW, ORBC Lower

